Immucell Corp

Biotech Stocks Healthcare Stocks

$10.05

+0.14 (+1.41%)

As of Jun 30, 10:39 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target -57.5% upside

Low Target $3.74

Average Target $4.27

High Target $6.64

Current Price $10.05

Current
$10.05

Target
$4.27

$3.74 $4.27 avg $6.64

Scenario Analysis

Bear Case

$3.74

-62.8%

Low target

Base Case

$4.27

-57.5%

Avg target

Bull Case

$6.64

+-33.9%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$10.75

-6.5% from high

52-Week Low

$4.52

+122.3% from low

Target vs 52W High

$4.27

-60.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%